A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray.
Abstract
Tissue microarrays (TMAs) provide unique resources for rapid evaluation and validation of tissue biomarkers. The Canary Foundation Retrospective Prostate Tissue Microarray Resource used a rigorous statistical design, quota sampling, a variation of the case-cohort study, to select patients for inclusion in a multicenter, retrospective prostate cancer TMA cohort. The study is designed to definitively validate tissue biomarkers of prostate cancer recurrence after radical prostatectomy. Tissue samples from over 1000 participants treated for prostate cancer with radical prostatectomy between 1995 and 2004 were selected at 6 participating institutions in the United States and Canada. This design captured the heterogeneity of screening and clinical practices in the contemporary North American population. Standardized clinical data were collected in a centralized database. The project has been informative in several respects. The scale and complexity of assembling TMAs with over 200 cases at each of 6 sites involved unanticipated levels of effort and time. Our statistical design promises to provide a model for outcome-based studies where tissue localization methods are applied to high-density TMAs.
Biomarkers
The following biomarkers make reference to this publication:
Protocols
One protocol is associated with this publication:
Authors
- Brooks JD
- Carroll PR
- Chan JM
- Cowan JE
- Crouch L
- Fazli L
- Feng Z
- Ferrari M
- Gleave M
- Hawley S
- Hernandez J
- Hurtado-Coll A
- Kuchinsky K
- Lance R
- Liew J
- Lin DW
- McKenney JK
- Mendez-Meza R
- Nelson PS
- Newcomb LF
- Nicolas M
- Simko J
- Smith E
- Tenggara I
- Thompson IM
- Troyer D
- True LD
- Zhang X